Accelerate Development With Large-Scale mRNA And LNP Production

Achieve scalable purity with Vernal’s mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments. Our high-purity mRNA production and advanced LNP formulations are designed to facilitate the advancement of lead candidates through preclinical development, providing larger quantities of high-quality material for vaccine development, gene therapy progression, and novel nanoparticle formulation discovery.

Key benefits include optimal efficacy and reliability, ensuring consistent, scalable results with minimal contaminants that could compromise potency or skew outcomes. Our precision-engineered LNP formulations enable confident delivery of therapeutic payloads to target-rich organs, while flexible production scales allow you to select options ranging from 1 mg to 25 grams to accommodate your research needs. With our seamless tech transfer process, you can expect consistent manufacturing that ensures a smooth transition from large-scale research use only (RUO) to clinical cGMP manufacturing.